Can an Eye Test Reveal Brain Changes in People With MS?

Credibility

Interest

Share:2 min read

Key Takeaway

In a study of 64 people with MS, slower signals on a vision test were linked to brain scan changes, even after researchers accounted for changes in the eye.

What They Found

Researchers gave 64 people with MS a vision test that measures how long it takes a signal to travel from each eye to the brain. They also used eye scans to measure the thickness of a nerve layer in the retina, the light-sensing part of the eye. Brain scans showed that people with slower vision signals tended to have less brain tissue overall. They also tended to have less gray matter, which helps the brain process information, and more areas that looked affected by MS. These links remained after researchers accounted for age and the nerve-layer measurement in the eye.

Who Should Care and Why

People with MS may find this useful because a vision test could offer another way to understand changes in the brain. The test measures signals rather than relying on someone to describe symptoms, which may help when changes are hard to notice. Caregivers may find it reassuring to know why an eye-related test could be discussed alongside a brain scan. If your care team orders this test, ask what your result means in light of your symptoms and other test results. Healthcare providers may eventually use it as one more piece of the puzzle, but this study does not show that it should replace a brain scan or change treatment.

Important Considerations

The study included only 64 people, so larger studies are needed to confirm the findings. It found a link between test results and brain scans, but did not show that a slow signal causes brain changes or predicts what will happen to an individual. It also did not test whether using the vision test improves care, so patients should not make treatment decisions based on this result alone.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Progression Specific Symptoms

Article Topics:

Brain volumeMultiple sclerosisOCTRNFLT2 hyperintensitiesVEP

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News